← Open Payments lookup

KENDALL KAUFMAN: Open Payments

NPI 1679828859 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,141 in 120 payments from 12 companies in 2025. Trend: 2023 $1,059 · 2024 $1,135 · 2025 $2,141

Food & beverage: $2,028Education: $113
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$565
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$448
Teva Pharmaceuticals USA, Inc.16$320
E.R. Squibb & Sons, L.L.C.18$202
Alkermes, Inc.11$195
Janssen Pharmaceuticals, Inc11$191
Vanda Pharmaceuticals Inc.4$87
Axsome Therapeutics, Inc.2$40
Lundbeck LLC2$37
Otsuka America Pharmaceutical, Inc.1$20

Products named: INGREZZA, CAPLYTA, COBENFY, INVEGA SUSTENNA, ARISTADA, UZEDY, FANAPT, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.